SCHEMBL934174

SCHEMBL934174

Cc1ccc(-c2cccc3c(O)c(C(=O)NCC(=O)O)c(=O)oc23)cc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL933166 0.91
SCHEMBL933928 0.89 EGLN1 (0.46)
SCHEMBL934000 0.89
SCHEMBL935133 0.89 EGLN2 (0.49)
SCHEMBL27961481 0.88
SCHEMBL15759105 0.87 EGLN1 (0.43)
SCHEMBL11934011 0.87 PTPRC (0.41)
SCHEMBL934468 0.86 EGLN2 (0.48)
SCHEMBL11934008 0.84 PRKDC (0.44)
SCHEMBL10009819 0.84

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2454249-B1 COMPOUNDS AS HYPOXIA MIMETICS, AND COMPOSITIONS, AND USES THEREOF BEIJING BETTA PHARMACEUTICALS CO LTD (CN) 2018-09-19 EP claimed
US-8742138-B2 Compounds as hypoxia mimetics, and compositions and uses thereof BETTA PHARMACEUTICALS CO., LTD. (CN) 2014-06-03 US claimed
US-20120172399-A1 COMPOUNDS AS HYPOXIA MIMETICS, AND COMPOSIITONS AND USES THEREOF BEIJING BETTA PHARMACEUTICALS CO., LTD. (CN) 2012-07-05 US claimed
EP-2454249-B1 COMPOUNDS AS HYPOXIA MIMETICS, AND COMPOSITIONS, AND USES THEREOF BEIJING BETTA PHARMACEUTICALS CO LTD (CN) 2018-09-19 EP disclosed
US-8742138-B2 Compounds as hypoxia mimetics, and compositions and uses thereof BETTA PHARMACEUTICALS CO., LTD. (CN) 2014-06-03 US disclosed
US-8742138-B2 Compounds as hypoxia mimetics, and compositions and uses thereof BETTA PHARMACEUTICALS CO., LTD. (CN) 2014-06-03 US disclosed
US-8742138-B2 Compounds as hypoxia mimetics, and compositions and uses thereof BETTA PHARMACEUTICALS CO., LTD. (CN) 2014-06-03 US disclosed
CN-102164905-B Compounds, compositions, and uses thereof as hypoxia mimetics BEIJING BETA PHARMA INC 2014-04-30 CN disclosed
US-20120172399-A1 COMPOUNDS AS HYPOXIA MIMETICS, AND COMPOSIITONS AND USES THEREOF BEIJING BETTA PHARMACEUTICALS CO., LTD. (CN) 2012-07-05 US disclosed
US-20120172399-A1 COMPOUNDS AS HYPOXIA MIMETICS, AND COMPOSIITONS AND USES THEREOF BEIJING BETTA PHARMACEUTICALS CO., LTD. (CN) 2012-07-05 US disclosed
US-20120172399-A1 COMPOUNDS AS HYPOXIA MIMETICS, AND COMPOSIITONS AND USES THEREOF BEIJING BETTA PHARMACEUTICALS CO., LTD. (CN) 2012-07-05 US disclosed
EP-2454249-A1 COMPOUNDS AS HYPOXIA MIMETICS, AND COMPOSITIONS, AND USES THEREOF Zhejiang Beta Pharma Inc. (CN) 2012-05-23 EP disclosed
CN-102164905-A Compounds, compositions, and uses thereof as hypoxia mimetics BEIJING BETA PHARMA INC 2011-08-24 CN disclosed
WO-2011006355-A1 COMPOUNDS AS HYPOXIA MIMETICS, AND COMPOSITIONS, AND USES THEREOF BEIJING BETA PHARMA INC. (CN) 2011-01-20 WO disclosed